The Compound Report is an educational resource. Nothing on this site constitutes medical advice or encourages personal use of any compound. Always consult a qualified healthcare provider.

Side by side

Compound comparison

Check interactions →Open as saved/share list

SHLP6

Research chemical · Grade C

Goals
cognition, longevity, mitochondria
Evidence
0 RCT / 0 animal / 0 in vitro
Routes
injectable-sc
WADA
No
FDA
Not approved
Cancer caution
hard-stop
Typical dose
—
Half-life
—
Primary mechanism
Mechanism diagram showing the compound's primary signaling pathway and downstream effects.
View full report →

Humanin

Research chemical · Grade C

Goals
cognition, longevity, mitochondria
Evidence
0 RCT / 0 animal / 0 in vitro
Routes
injectable-sc
WADA
S4
FDA
Not approved
Cancer caution
hard-stop
Typical dose
—
Half-life
—
Primary mechanism
Mechanism diagram showing the compound's primary signaling pathway and downstream effects.
View full report →

SHLP2

Research chemical · Grade C

Goals
cognition, longevity, weight-loss, mitochondria
Evidence
0 RCT / 0 animal / 0 in vitro
Routes
injectable-sc
WADA
No
FDA
Not approved
Cancer caution
caution
Typical dose
—
Half-life
—
Primary mechanism
Mechanism diagram showing the compound's primary signaling pathway and downstream effects.
View full report →

MOTS-c

Research chemical · Grade C

Goals
mitochondria, longevity, weight-loss, muscle
Evidence
0 RCT / 12 animal / 0 in vitro
Routes
injectable-sc
WADA
S4
FDA
Not approved
Cancer caution
caution
Typical dose
—
Half-life
Plasma half-life is estimated at approximately 30-60 minutes in animal models, but human clearance has not been measured
Primary mechanism
Mechanism diagram showing the compound's primary signaling pathway and downstream effects.
View full report →